Guideline Title
Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events.
Bibliographic Source(s)
National Institute for Health and Clinical Excellence (NICE). Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events. London (UK): National Institute for Health and Clinical Excellence (NICE); 2010 Dec. 42 p. (Technology appraisal guidance; no. 210). |
Guideline Status
This is the current release of the guideline.
This guideline updates a previous version: National Institute for Health and Clinical Excellence (NICE). Clopidogrel and modified-release dipyridamole in the prevention of occlusive vascular events. London (UK): National Institute for Health and Clinical Excellence (NICE); 2005 May. 34 p. (Technology appraisal; no. 90).
This guideline updates a previous version: National Institute for Health and Clinical Excellence (NICE). Clopidogrel and modified-release dipyridamole in the prevention of occlusive vascular events. London (UK): National Institute for Health and Clinical Excellence (NICE); 2005 May. 34 p. (Technology appraisal; no. 90).
full-text:
National Guideline Clearinghouse Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events.
No hay comentarios:
Publicar un comentario